advertisement
11.13.4 Betablocker and prostaglandin (21)
Showing records 1 to 21
Display all abstracts in classification 11.13.4 Betablocker and prostaglandin
Search within classification 11.13.4 Betablocker and prostaglandin60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Pfeiffer N
Advances in Therapy 2014; 31: 1228-1246
60147 Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study
García-López A
BMC Ophthalmology 2014; 14: 161
60175 The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies
Radcliffe NM
Clinical Ophthalmology 2014; 8: 2541-2549
60383 Safety and tolerability of the tafluprost/timolol fixed combination for the treatment of glaucoma
Holló G
Expert Opinion on Drug Safety 2015; 14: 609-617
60317 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Rossetti L; Sacchi M
BMC Ophthalmology 2015; 15: 7
60147 Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study
Paczka JA
BMC Ophthalmology 2014; 14: 161
60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Traverso CE
Advances in Therapy 2014; 31: 1228-1246
60383 Safety and tolerability of the tafluprost/timolol fixed combination for the treatment of glaucoma
Katsanos A
Expert Opinion on Drug Safety 2015; 14: 609-617
60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Lorenz K
Advances in Therapy 2014; 31: 1228-1246
60317 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Karabatsas CH
BMC Ophthalmology 2015; 15: 7
60147 Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study
Jiménez-Román J; Hartleben C
BMC Ophthalmology 2014; 14: 161
60317 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Topouzis F
BMC Ophthalmology 2015; 15: 7
60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Saarela V
Advances in Therapy 2014; 31: 1228-1246
60317 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Vetrugno M
BMC Ophthalmology 2015; 15: 7
60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Liinamaa J; Uusitalo H
Advances in Therapy 2014; 31: 1228-1246
60317 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Centofanti M; Boehm A
BMC Ophthalmology 2015; 15: 7
60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Astakhov Y
Advances in Therapy 2014; 31: 1228-1246
60317 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Vorwerk C
BMC Ophthalmology 2015; 15: 7
60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Boiko E; Ropo A
Advances in Therapy 2014; 31: 1228-1246
60317 Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on 24-hour blood and ocular perfusion pressures: the results of a randomized trial
Goldblum D; Fogagnolo P
BMC Ophthalmology 2015; 15: 7
60017 A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components
Advances in Therapy 2014; 31: 1228-1246